title: Lowering methodological standards for studies of multidrug-resistant bacteria is counterproductive.
authors.affiliation: Infectious Diseases Institute, Rambam Health Care Campus and The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel. Electronic address: paulm@post.tau.ac.il.
authors.forename: M
authors.initials: M
authors.lastname: Paul
authors.affiliation: Infectious Diseases Institute, Rambam Health Care Campus and The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.
authors.forename: K
authors.initials: K
authors.lastname: Hussein
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans
chemical_list: D000900:Anti-Bacterial Agents